JAMES DISNEY: Open Payments
NPI 1962603506 · CONCORD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,346 in 42 payments from 8 companies in 2025. Trend: 2023 $259 · 2024 $583 · 2025 $1,346
Food & beverage: $1,346
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 5 | $368 |
| E.R. Squibb & Sons, L.L.C. | 8 | $366 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $192 |
| Teva Pharmaceuticals USA, Inc. | 15 | $181 |
| Alkermes, Inc. | 5 | $103 |
| Janssen Pharmaceuticals, Inc | 2 | $103 |
| Luye Pharma (USA) Ltd. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: INGREZZA, COBENFY, CAPLYTA, AUSTEDO XR, ARISTADA, INVEGA SUSTENNA, UZEDY, ERZOFRI EXTENDED-RELEASE.
Industry payments across NC — which companies pay providers there.
